Publication:
Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

dc.contributor.authorHernández-García, Marta
dc.contributor.authorMolina-Barceló, Ana
dc.contributor.authorVanaclocha-Espi, Mercedes
dc.contributor.authorZurriaga, Óscar
dc.contributor.authorPerez-Gomez, Beatriz
dc.contributor.authorAragones, Nuria
dc.contributor.authorAmiano, Pilar
dc.contributor.authorAltzibar, Jone M
dc.contributor.authorCastaño-Vinyals, Gemma
dc.contributor.authorSala, María
dc.contributor.authorEderra, María
dc.contributor.authorMartín, Vicente
dc.contributor.authorGómez-Acebo, Inés
dc.contributor.authorVidal, Carmen
dc.contributor.authorTardón, Adonina
dc.contributor.authorMarcos-Gragera, Rafael
dc.contributor.authorPollan-Santamaria, Marina
dc.contributor.authorKogevinas, Manolis
dc.contributor.authorSalas, Dolores
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderFundación Marqués de Valdecilla
dc.contributor.funderInternational Cancer Genome Consortium
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderRed Temática de Investigación Cooperativa en Cáncer (RTICC) (España)
dc.contributor.funderJunta de Castilla y León (España)
dc.contributor.funderRegional Government of Andalusia (España)
dc.contributor.funderGeneralitat Valenciana (España)
dc.contributor.funderBasque Government (España)
dc.contributor.funderGobierno de la Región de Murcia (España)
dc.contributor.funderUnión Europea. Comisión Europea
dc.contributor.funderFundación La Caixa
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderGovernment of Catalonia (España)
dc.contributor.funderAgència de Gestió d´Ajuts Universitaris i de Recerca (AGAUR)
dc.contributor.funderFundación Caja de Ahorros de Asturias
dc.contributor.funderUniversity of Oviedo (España)
dc.date.accessioned2022-05-26T11:21:22Z
dc.date.available2022-05-26T11:21:22Z
dc.date.issued2022-01
dc.description.abstractPurpose: The variation in breast cancer (BC)-risk factor associations between screen-detected (SD) and non-screen-detected (NSD) tumors has been poorly studied, despite the interest of this aspect in risk assessment and prevention. This study analyzes the differences in breast cancer-risk factor associations according to detection method and tumor phenotype in Spanish women aged between 50 and 69. Methods: We examined 900 BC cases and 896 controls aged between 50 and 69, recruited in the multicase-control MCC-Spain study. With regard to the cases, 460 were detected by screening mammography, whereas 144 were diagnosed by other means. By tumor phenotype, 591 were HR+, 153 were HER2+, and 58 were TN. Lifestyle, reproductive factors, family history of BC, and tumor characteristics were analyzed. Logistic regression models were used to compare cases vs. controls and SD vs. NSD cases. Multinomial regression models (controls used as a reference) were adjusted for case analysis according to phenotype and detection method. Results: TN was associated with a lower risk of SD BC (OR 0.30 IC 0.10-0.89), as were intermediate (OR 0.18 IC 0.07-0.44) and advanced stages at diagnosis (OR 0.11 IC 0.03-0.34). Nulliparity in postmenopausal women and age at menopause were related to an increased risk of SD BC (OR 1.60 IC 1.08-2.36; OR 1.48 IC 1.09-2.00, respectively). Nulliparity in postmenopausal women was associated with a higher risk of HR+ (OR 1.66 IC 1.15-2.40). Age at menopause was related to a greater risk of HR+ (OR 1.60 IC 1.22-2.11) and HER2+ (OR 1.59 IC 1.03-2.45) tumors. Conclusion: Reproductive risk factors are associated with SD BC, as are HR+ tumors. Differences in BC-risk factor associations according to detection method may be related to prevailing phenotypes among categories.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis research was supported by Acción Transversal del Cáncer, approved by the Spanish Council of Ministeres on the 11th October 2007, by the Carlos III Health Institute-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/ 01662, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI11/01810, PI14/01219, PI11/02213, PIE16/00049, PI17/01179, PI17-00092), by the Fundación Marqués de Valdecilla (API 10/09), by the ICGC International Cancer Genome Consortium CLL (the ICGC CLL-Genome Project is funded by the Spanish Ministry of Economy and Competitiveness through the Carlos III Health Institute (ISCIII)), by the ISCIII Red Temática de Investigación del Cáncer (RTICC) (RD12/0036/0036), by the Regional Government of Castile and León (LE22A10-2), by the Regional Health Ministry of Andalusia (PI-0571–2009, PI-0306–2011, salud201200057018tra), by the Regional Health Ministry of Valencia (AP_061/10), by Recercaixa (2010ACUP00310), by the Regional Government of the Basque Country, by the Regional Health Ministry of Murcia, by the European Commission (grants FOOD-CT-2006–036224-HIWATE), by the Spanish Association Against Cancer (AECC) Scientific Foundation (GCTRA18022MORE), by the Catalan Regional Government Agency for Management of University and Research Grants (AGAUR) (2014SGR647, 2014SGR850, and 2017SGR723), by the Fundación Caja de Ahorros de Asturias and by the University of Oviedo. ISGlobal is a member of the CERCA Programme, Regional Government of Catalonia. Sample collection was supported by the Carlos III Health Institute- FEDER: Parc de Salut MAR Biobank (MARBiobanc) (RD09/0076/00036), the La Fe Biobank (PT17/0015/0043RD 09 0076/00021), and the FISABIO Biobank (PT17/0015/0017) RD09 0076/00058);es_ES
dc.format.number1es_ES
dc.format.page125-136es_ES
dc.format.volume33es_ES
dc.identifier.citationCancer Causes Control 2022 Jan;33(1):125-136.es_ES
dc.identifier.doi10.1007/s10552-021-01511-4es_ES
dc.identifier.e-issn1573-7225es_ES
dc.identifier.journalCancer Causes & Control: CCCes_ES
dc.identifier.pubmedID34817770es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14549
dc.language.isoenges_ES
dc.publisherSpringer
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD12%2F0036%2F0036/ES/Cáncer/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//RD09%2F0076%2F00036/ES/RED DE BIOBANCOS/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//RD09%2F0076%2F00058/ES/RED DE BIOBANCOS/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//RD09%2F0076%2F00021/ES/RED DE BIOBANCOS/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PT17/0015/0043es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PT17/0015/0017es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PS09%2F00773/ES/ESTUDIO MULTICASO-CONTROL DE BASE POBLACIONAL (CANCER DE MAMA, CANCER COLORRECTAL, CANCER GASTRO-ESOFAGICO Y CANCER DE PROSTATA)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PS09%2F01286/ES/ESTUDIO MULTICASO-CONTROL DE BASE POBLACIONAL (CANCER DE MAMA, CANCER COLORRECTAL, CANCER GASTRO-ESOFAGICO Y CANCER DE PROSTATA)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PS09/01903es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PS09%2F02078/ES/ESTUDIO MULTICASO-CONTROL DE BASE POBLACIONAL (CANCER DE MAMA, CANCER COLORRECTAL, CANCER GASTRO-ESOFAGICO Y CANCER DE PROSTATA)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PS09%2F01662/ES/ESTUDIO MULTICASO-CONTROL DE BASE POBLACIONAL (CANCER DE MAMA, CANCER COLORRECTAL, CANCER GASTRO-ESOFAGICO Y CANCER DE PROSTATA)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PI11%2F01403/ES/Etiopatogenia del cáncer gástrico en España: Posible interacción microbiano-ambiental en un estudio multicéntrico de casos y controles de base poblacional (MCC-Spain Gastric Cancer)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PI11%2F00226/ES/Riesgo de cáncer colorrectal en España por carcinógenos en agua de consumo/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PI15%2F00069/ES/Integración de big data genéticos y datos clínicos: supervivencia con cáncer de mama en el estudio MCC-Spain/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PI15%2F00914/ES/INTEGRACIÓN DE BIG DATA GENÉTICOS Y DATOS CLÍNICOS: SUPERVIVENCIA Y CALIDAD DE VIDA EN PARTICIPANTES CON CÁNCER DE PRÓSTATA EN EL ESTUDIO MCC-Spain/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PI15%2F01032/ES/Supervivencia de cáncer colorrectal en el proyecto MCC-Spain: Modelos de predicción que integran datos genéticos y clínico-epidemiológicos/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PI11%2F01810/ES/Factores de riesgo ambientales, infecciosos y genéticos asociados a la leucemia linfática crónica (LLC), en el marco del estudio Multi-Caso-Control (MCC-SPAIN)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PI14%2F01219/ES/Perfil molecular del envejecimiento en la patogénesis y pronóstico de la leucemia linfática crónica/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN//PI11%2F02213/ES/ESTUDIO MULTICASO-CONTROL DE BASE POBLACIONAL (CÁNCER DE MAMA y LLC)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PIE16%2F00049/ES/SCREENING SIGNATURE OF ENDOMETRIAL AND OVARIAN CANCERS: OPTIONS FOR EARLY DETECTION (SCREENWIDE)/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI08/1770es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI08/0533es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI08/1359es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI11/01889-FEDERes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI12/00488es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI12/00265es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI12/01270es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI12/00715es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI12/00150es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI14/0613es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI17/01179es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI17/00092es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/CE/FOOD-CT-2006–036224-HIWATEes_ES
dc.relation.publisherversionhttps://doi.org/10.1007/s10552-021-01511-4es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBreast neoplasmes_ES
dc.subjectEarly detection of canceres_ES
dc.subjectPhenotypees_ES
dc.subjectRisk factorses_ES
dc.titleDifferences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication4b7eabf1-df99-4684-9c92-42bc37de6a41
relation.isAuthorOfPublicationbdb2687b-1299-4a83-9603-d7d83ab19b62
relation.isAuthorOfPublication57cdf9f1-5836-41aa-9880-cf773b0e65f9
relation.isAuthorOfPublicationcb3b77d8-c78c-4238-9b9d-c1171ff3ab51
relation.isAuthorOfPublication.latestForDiscovery4b7eabf1-df99-4684-9c92-42bc37de6a41
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication65f5f3a7-1937-4dbd-aa46-55df595bfa5d
relation.isFunderOfPublication9f6bc58f-51f7-48ec-a642-79dc5e524322
relation.isFunderOfPublication77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isFunderOfPublication3fb2c806-a1bc-429e-99df-4c2e50f8a129
relation.isFunderOfPublicationd1a8e7e7-3324-4d09-b435-4b96717a7edf
relation.isFunderOfPublicationa16348d3-7483-4017-92f4-0f4f47980d57
relation.isFunderOfPublication842e6617-7822-4501-a927-7e8cedda4aa6
relation.isFunderOfPublication6b0fdff7-65d0-4c97-9d9f-0ddb2b20aabe
relation.isFunderOfPublicationc6d15272-88a9-499b-9579-6f7e25795a56
relation.isFunderOfPublication639cecfa-9455-4e7f-9f65-9ece17a878f0
relation.isFunderOfPublicationf04d23ec-a91d-4242-88b0-cc436888f8a2
relation.isFunderOfPublication453a1189-9bca-4be8-8d60-695f50fe028b
relation.isFunderOfPublicationc6fbffec-abb4-4f0e-81e0-3b254d5dd85d
relation.isFunderOfPublicationaf365449-d1bb-4678-af42-7483b561cd83
relation.isFunderOfPublication937e1afd-baa0-4b8f-89fe-063355acebb1
relation.isFunderOfPublicationd94cc2da-aec2-4350-9f43-b1eb7dafa34f
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication8d558850-2ef2-4d1e-b0e1-4e5591ab6288
relation.isPublisherOfPublication.latestForDiscovery8d558850-2ef2-4d1e-b0e1-4e5591ab6288

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
DifferencesInBreastCancer_2021.pdf
Size:
579.01 KB
Format:
Adobe Portable Document Format
Description:
Artículo principal
Loading...
Thumbnail Image
Name:
DifferencesInBreastCancerSupplementary_2021.docx
Size:
17.08 KB
Format:
Microsoft Word XML
Description:
Material Suplementario